BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18978109)

  • 1. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
    Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
    Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
    Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.
    Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM
    Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
    Spencer K; Cowans NJ
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
    Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
    Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
    Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
    J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.
    Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome.
    Pihl K; Larsen T; Laursen I; Krebs L; Christiansen M
    Prenat Diagn; 2009 Dec; 29(13):1256-61. PubMed ID: 19911417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters.
    El-Sherbiny W; Nasr A; Soliman A
    Hypertens Pregnancy; 2012; 31(4):442-50. PubMed ID: 22676623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM12: a novel first-trimester maternal serum marker for Down syndrome.
    Laigaard J; Sørensen T; Fröhlich C; Pedersen BN; Christiansen M; Schiøtt K; Uldbjerg N; Albrechtsen R; Clausen HV; Ottesen B; Wewer UM
    Prenat Diagn; 2003 Dec; 23(13):1086-91. PubMed ID: 14691998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
    Cowans NJ; Spencer K
    Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
    Poon LC; Nekrasova E; Anastassopoulos P; Livanos P; Nicolaides KH
    Prenat Diagn; 2009 Jun; 29(6):553-9. PubMed ID: 19242924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM12s in maternal serum as a potential marker of pre-eclampsia.
    Spencer K; Cowans NJ; Stamatopoulou A
    Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.
    Yang J; Wu J; Guo F; Wang D; Chen K; Li J; Du L; Yin A
    PLoS One; 2014; 9(5):e97284. PubMed ID: 24830297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
    Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
    Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.